All Articles
February is National Cancer Prevention Month! Check out this slideshow full of information relating to the detection and prevention of cancer, including the 4 leading causes of cancer in the US. Conquer cancer with knowledge. Read More ›
Do cell phones cause cancer? Does deodorant cause breast cancer? These common myths and more explored in this slideshow. Read More ›
For the first time in 40 years, patients who are considering reconstructive surgery after a mastectomy because of breast cancer have a new option for tissue expansion—the AeroForm Tissue Expander System. Read More ›
In 2017, the FDA approved two new treatments for patients with hepatocellular carcinoma (HCC), Stivarga and Opdivo. Read about these new treatments for liver cancer. Read More ›
In November 2017, the FDA approved Alecensa for the treatment of all patients with metastatic non–small-cell lung cancer (NSCLC) and ALK mutation. Read More ›
In October 2017, the FDA accelerated the approval of Calquence for the treatment of adults with mantle-cell lymphoma who have received at least 1 previous therapy. Read More ›
Read about Verzenio, which was approved by the FDA in 2017, in combination with fulvestrant, for treatment of women with HR-positive, HER2-positive, HER2-negative advanced, or metastatic breast cancer that progressed after endocrine therapy. Read More ›


